This is Part 3 of our 8-part GLP-1 Weight Loss Series. Catch up on Part 1: Semaglutide vs. Tirzepatide and Part 2: How to Get a GLP-1 Online. Up next in Part 4: side effects and how to manage them. Today: what these medications actually cost in 2026 — and every way to pay less.
How Much Do GLP-1 Weight-Loss Drugs Cost in 2026?
Here’s the honest answer: the list price of a GLP-1 is roughly $1,000–$1,650 per month, but almost nobody pays that. What you’ll actually pay depends entirely on which “door” you go through — insurance, a manufacturer cash-pay program, or a government option. Through the cheapest doors, the same medication can cost as little as $25–$199 a month. This guide maps every channel so you can find your lowest legitimate price.
The short version
- List price: Wegovy ~$1,350–$1,640/mo; Zepbound ~$1,271/mo — before any discount.
- With commercial insurance + a savings card: as low as ~$25 per fill when your plan covers weight-loss meds.
- Manufacturer cash-pay (no insurance): roughly $199–$449/mo depending on drug and dose.
- Medicare GLP-1 Bridge: $50/mo for eligible members, running July 2026 through 2027.
- The single biggest cost factor is whether your specific plan covers weight-loss medication — worth checking before anything else.
What You’ll Pay, Channel by Channel
The GLP-1 pricing world changed fast in 2025–26, with new manufacturer programs and a federal portal reshaping what people pay. Here’s how the main paths compare as of 2026.
| How you pay | Typical monthly cost | Best for |
|---|---|---|
| Commercial insurance + savings card | ~$25–$50 per fill | Plans that cover weight-loss medication |
| Medicare GLP-1 Bridge | $50 / month | Eligible Medicare members (July 2026–2027) |
| Manufacturer direct-pay (NovoCare for Wegovy, LillyDirect for Zepbound) |
~$199–$449 / month by dose | Uninsured or plans that don’t cover GLP-1s |
| Full list price (no coverage, no program) | ~$1,000–$1,640 / month | Almost no one should pay this — check the options above first |
Sources: manufacturer NovoCare and LillyDirect programs; Medicare GLP-1 Bridge program; 2026 GLP-1 pricing trackers. Prices change frequently — confirm current pricing with your provider and pharmacy.
Will Insurance Cover a GLP-1?
Sometimes — and it’s the first thing to check, because it’s usually the cheapest path. Coverage falls into a few buckets:
- For type 2 diabetes: Ozempic and Mounjaro are widely covered, since they’re approved diabetes medications.
- For weight loss specifically: coverage of Wegovy and Zepbound is more mixed. Many commercial plans cover them; many don’t, or require prior authorization and a documented BMI.
- With a savings card: if your commercial plan covers the drug, a manufacturer savings card can bring your cost down to roughly $25 per fill.
Tip: Before you assume a GLP-1 is out of reach, have someone check your specific plan’s formulary for weight-loss coverage and any prior-authorization requirements. WeHealth can help verify your coverage as part of your evaluation — see insurance and pricing.
Cash-Pay Options If You’re Not Covered
If your plan doesn’t cover weight-loss medication, you’re far from stuck. Manufacturer direct-pay programs have brought cash prices way down from the old list prices:
- NovoCare Pharmacy (Wegovy): direct-pay pricing that, with current promotions, can run from roughly $199 for lower doses up to the mid-$300s.
- LillyDirect (Zepbound): direct-pay pricing roughly $299–$449/month depending on dose.
- TrumpRx.gov: a federal portal launched in February 2026 that routes patients to those manufacturer direct-pay channels — a convenient front door, not a separate discount.
A caution on “cheap” GLP-1s: If you see semaglutide or tirzepatide advertised for far less than the prices above, it’s very likely a compounded or unapproved product. The FDA ended the legal allowance for mass-compounding these drugs in 2025. Cheaper isn’t worth it if you can’t trust the dose or purity — see Part 2 for the red flags.
Is a GLP-1 Worth the Cost?
That’s a personal call, but it helps to look at the whole picture rather than just the monthly number. Clinical trials show meaningful average weight loss — around 15% on semaglutide and up to about 21% on tirzepatide — which for many people also improves blood pressure, blood sugar, and other weight-related conditions. Some of those downstream health costs may fall as your weight does. A doctor can help you weigh the medication cost against your personal health goals and what your body responds to.
Good to know: The cheapest medication is the one that works and that you can sustain. Pairing a GLP-1 with nutrition coaching — included in WeHealth’s medical weight-loss program — helps protect the results you’re paying for.
How WeHealth Helps You Pay Less
WeHealth connects you with board-certified Obesity Medicine doctors who prescribe FDA-approved GLP-1s, and helps you find your lowest legitimate price along the way.
- We verify your insurance coverage as part of your evaluation
- We prescribe FDA-approved medications eligible for manufacturer savings programs
- Most insurance is accepted for your visits
- Coaching, labs, and dose adjustments are included — so you get more value from the medication
Download the WeHealth app to start your evaluation, or check insurance and pricing first.
Frequently Asked Questions
How much does a GLP-1 cost per month in 2026?
It ranges widely. List price is about $1,000–$1,640/month, but with commercial insurance and a savings card it can be as low as ~$25 per fill, eligible Medicare members can pay $50/month through the GLP-1 Bridge program, and manufacturer cash-pay programs run roughly $199–$449/month. Your actual cost depends on your coverage and the drug.
Does insurance cover Wegovy or Zepbound for weight loss?
Coverage for weight-loss use is mixed. Many commercial plans cover Wegovy and Zepbound, often with prior authorization and a documented BMI; others don’t cover weight-loss medication at all. Ozempic and Mounjaro are widely covered for type 2 diabetes. Checking your specific plan’s formulary is the best first step.
What is the Medicare GLP-1 Bridge program?
It’s a program that offers eligible Medicare beneficiaries access to certain FDA-approved GLP-1 weight-loss medications — including Wegovy and Zepbound — for $50 per month, running from July 2026 through 2027. Eligibility rules apply, so confirm your status with your plan.
What is TrumpRx?
TrumpRx.gov is a federal portal launched in February 2026 that directs patients to manufacturers’ own direct-pay programs, such as NovoCare and LillyDirect. It’s a routing tool rather than a separate discount — the pricing you get is the manufacturer’s cash-pay price.
Why are some online GLP-1s so much cheaper?
Prices well below manufacturer cash-pay are usually compounded or unapproved products. The FDA ended the legal allowance for mass-compounding semaglutide and tirzepatide in 2025. A price that seems too good to be true is a red flag for dose and purity you can’t verify.
Can WeHealth help me find the lowest price?
Yes. As part of your evaluation, WeHealth verifies your insurance coverage and prescribes FDA-approved medications eligible for manufacturer savings programs, helping you land on your lowest legitimate cost. Most insurance is accepted for the visit itself.
Coming Up in Part 4
Next: GLP-1 Side Effects — What’s Normal, What’s Not, and How to Manage Them. We’ll cover the common early side effects, which ones fade, the warning signs that need a doctor, and the practical tricks that make the first few weeks easier.
Ready to Find Your Price?
The best way to know what a GLP-1 will cost you is to have your coverage checked by a real care team. Download the WeHealth app to start your evaluation, or check insurance and pricing. Most insurance accepted — no waiting room.
Medical Disclaimer: This article is for informational purposes only and is not a substitute for medical advice, diagnosis, or treatment from a qualified healthcare provider. Drug prices, insurance coverage, and government programs change frequently and vary by individual; confirm current details with your provider, plan, and pharmacy. GLP-1 medications are prescription drugs with risks and contraindications. Written by the WeHealth Medical Team. Medically reviewed by [Reviewer Name], MD, Board-Certified in Obesity Medicine. Last updated: August 25, 2026.